| BDC PORTFOLIO Weighted Average Data |
|||
|---|---|---|---|
| Discount 16.49% |
1Yr Disc 10.53% |
3Yr Disc 20.12% |
5Yr Disc 19.66% |
| Rel Disc Range (3yr) 49.50% |
Premium Days (1yr) 67.46% |
Premium Days (3yr) 77.42% |
2 Year Beta 0.82 |
| NII Coverage 129.60% |
Core NII Coverage 131.25% |
Market Yield 10.08% |
Lev Adj NAV Yield 7.71% |
| 3YR NAV TR 55.06% |
Last Q NAV TR 3.11% |
Last Q NAV Growth -0.01% |
Non-accrual 1.17% |
| Total Lev 51.83% |
Est Lev Cost 6.92% |
Fixed Lev 60.23% |
Variable Assets 87.54% |
| Debt % 92.04% |
1st Lien % 73.89% |
2nd Lien % 12.67% |
Maturity 3.41 |
| FMV vs Cost -1.43% |
Gross Non Lev Exp Ratio 2.54% |
#Loans 4,164 |
#Companies 2,064 |
| * Weighted data relative to full portfolio allocation | |||
| TOTAL RETURNS Weighted Average Data |
|||||
|---|---|---|---|---|---|
| 1MO | 3MO | 6MO | 1YR | 3YR | |
| Price | 2.66% | 9.62% | 21.42% | 22.36% | 68.55% |
| NAV | 1.95% | 3.27% | 7.12% | 13.23% | 55.06% |
| INCOME | |||
|---|---|---|---|
| Pending Distribution 1.35% |
|||
| Top Ten Portfolio Companies Weighted Average Data |
||
|---|---|---|
| 1 | Ivy Hill Asset Management, L.P. | 0.9% |
| 2 | Axsome Therapeutics, Inc. | 0.6% |
| 3 | Senior Direct Lending Program, LLC | 0.5% |
| 4 | Corium, Inc. | 0.5% |
| 5 | I-45 SLF, LLC | 0.5% |
| 6 | Lithium Technologies, Inc | 0.5% |
| 7 | Flip Electronics LLC | 0.5% |
| 8 | Worldremit Group Limited | 0.4% |
| 9 | Prodigy Finance Limited | 0.4% |
| 10 | NINJATRADER, LLC | 0.4% |
| Top Ten States Weighted Average Data |
||
|---|---|---|
| 1 | DE | 17.0% |
| 2 | CA | 15.5% |
| 3 | TX | 9.5% |
| 4 | NY | 8.0% |
| 5 | MA | 4.2% |
| 6 | FL | 3.8% |
| 7 | IL | 2.9% |
| 8 | WA | 2.0% |
| 9 | CO | 1.9% |
| 10 | NJ | 1.8% |
DISCLOSURES:
CEFData.com makes data for the universe of closed-end funds (CEFs) and business development companies (BDCs) available to its users. This material is not intended to be relied upon as investment advice or recommendations, does not constitute a solicitation to buy or sell securities and should not be considered specific legal, investment or tax advice. This site does not list all the risks associated with each fund. Investors should contact a fund’s sponsor for fund-specific risk information and/or contact a financial advisor before investing.
NOTES: Distribution type sourced from CEFdata.com. For specific information about a fund's distribution sources, visit the fund sponsor's website.
The following information applies to closed-end funds and business development companies in general: Fund shares are not guaranteed or endorsed by any bank or other insured depository institution, and are not federally insured by the Federal Deposit Insurance Corporation (FDIC). Shares of closed-end funds (CEFs) and business development companies (BDCs) are subject to investment risks, including the possible loss of principal invested. There can be no assurance that fund objectives will be achieved. Closed-end funds and business development companies frequently trade at a discount to their net asset value. NAV returns are net of fund expenses, and assume reinvestment of distributions.
This material is presented for informational purposes only. Under no circumstances is it to be considered an offer to sell, or a solicitation to buy any investment referred to on this page. While the information contained herein is from sources believed reliable, we do not represent that it is accurate or complete and it should not be relied upon as such. Past performance is not necessarily indicative of future results. All investments involve risk including the loss of principal. Returns are presented gross of investment management fees and other appropriate fees (i.e. commissions, custodial fees, etc.).
© Closed-End Fund Advisors Inc.(CEFadvisors) and CEFdata.com 2019. All rights reserved. Any copying, republication or redistribution of CEFadvisors, CEFdata.com, content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of CEFAdvisors. CEFAdvisors shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.